1 / 39

Cardiac Arrhythmias 2015

Cardiac Arrhythmias 2015. Christopher L. Fellows, MD, FACC, FHRS Virginia Mason Medical Center Seattle, Wa. NEI CHING SU WEN The Yellow Emperor's Classic Textbook of Internal Medicine. “When the pulse is irregular and tremulous and the beats occur at intervals, then the

stanleyolson
Download Presentation

Cardiac Arrhythmias 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cardiac Arrhythmias 2015 Christopher L. Fellows, MD, FACC, FHRS Virginia Mason Medical Center Seattle, Wa.

  2. NEI CHING SU WENThe Yellow Emperor's Classic Textbook of Internal Medicine “When the pulse is irregular and tremulous and the beats occur at intervals, then the impulse of life fades” Huang Ti Circa 2696-2598 BC

  3. Hering HE. Das Elektrocardiogramm des Irregularis perpetuus. Deutsches Archiv fur Klinische Medizin. 1908; 94:205-8.

  4. 2014 AHA/ACC/HRS Guidelines for the Management of AF • 2011 Focused Update on the management of AF • 2012 Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation www.acc.orgwww.hrsonline.org

  5. National Coverage Determination (NCD). The following indications are covered: • 1. Documented non-reversible symptomatic bradycardia due to sinus node dysfunction. • 2. Documented non-reversible symptomatic bradycardia due to second degree and/or third degree atrioventricular block. 8/13/2013

  6. Basic Arrhythmology • Take a good history • Document the arrhythmia • Symptom/rhythm correlation • Evaluate for structural heart disease • Precipitating factors (T4, Electrolytes, ETOH)

  7. Why treat ? • Symptoms (palps to syncope) • Prevent Cardiac Arrest • Prevent stroke (AF) • Prevent worsening of Arrhythmogenic substrate • Prevent Arrhythmia induced myopathy

  8. Rate related cardiomyopathy

  9. Tachy-cardiomyopathy • 1913 Gossage and Braxton Hicks described a case of AF in a young man who developed CHF …. “which might very well have been a consequence not a cause of the auricular fibrillation” Gossage AM, Braxton Hicks JA Q J Med 1913;6:435-40.

  10. “auricular fibrillation, apart from any other disease of the heart, may cause severe congestive failure and that upon cessation of the arrhythmia the congestive failure may be followed by complete and lasting recovery” I. C. Brill, 1937

  11. What tools do we have ? • Drugs • Pacers • ICDs • Ablation

  12. What tools do we have ? • Drugs • Pacers • ICDs • Ablation

  13. AF is very frustrating • Causes strokes…strokes are BAD • Makes pts feel BAD • Therapy toxic and ineffective

  14. Is Sinus Rhythm Important ? • AFFIRM (Wyse DG, et.al. NEJM 2002;347:1825-31) • RACE (Hagens VE, et.al. JACC 2004;43:241-247.) • STAF (Carlsson J, et.al. JACC 2003;41:1690-1696.) All concluded …..that there were no mortality differences between rate control and rhythm control strategies in the treatment of AF

  15. Sinus Rhythm • AFFIRM type trials excluded highly symptomatic patients • Trials designed to test strategy not therapy • Therapy was very ineffective

  16. AFFIRM Substudy • On treatment analysis • NSR= 47% lower risk of death • AAD use = 49% increased risk of death AFFIRM investigators. Circ 2004;109:1509-1413

  17. “…the failure of AFFIRM, RACE, or STAF in showing any differences between rate and rhythm control is not so much a positive statement for rate control but rather a testimony on the ineffectiveness of the rhythm control methods used.” Verma A, Natale A. Circulation 2005;112:1214-1231.

  18. OK, Sinus rhythm is good but at what price ? • Drugs • Pacer • ICD • Ablation

  19. OK, Sinus rhythm is good but at what price ? • Drugs • Pacer • ICD • Ablation

  20. “… the success of Pulmonary Vein Antral Isolation can exceed 90%, sometimes requiring 2 procedures, and there is an associated risk of stroke <1%, cardiac perforation <1%, pulmonary vein stenosis <1%, vascular injury <1%, and atrioesophageal fistula 1/1000.”

  21. Results • Worldwide data* (100 centers), 52% efficacy (27% repeats) 6% complications • US data** (92 centers) 66% efficacy *Cappato R, Calkins H, Chen S et.al Circ. 2005;111:1100-1105. **Mickelson S, Dudley B, Treat E, et.al. JICE 2005;12:213-220.

  22. Published Catheter Ablation Success Rates N = 63 studies 6936 pts Success Rates Catheter Ablation Major complications 4.9% Calkins H, et al. Circulation. 2009;2:349-361.

  23. Recent RF study • SMART-AF prospective trial (N=161) • Contact force catheter • Very experienced operators • 72.5% 12 month freedom from AF compared to 66% (open irrigated) • 4 perforation/tamponade (2.48%) Natale A, et.al, JACC 2014;64:647-56.

  24. Cryoablation • 1948 (Hass) surgical Cryo lesions in Cardiac surgery using CO2 • 1963 (Cooper) developed liquid nitrogen surgical cryo tools • 1977 (Gallagher) reported AVN ablation using surgical cryoablation • 1991 (Gillette) cryoablation catheter in animals • 1999 (Dubuc) cryocatheter in humans

  25. Cryoballoon results 2/11 – 10/14(CF) • N=595 (male 72%) • Ages 29-84 • All symptomatic, documented multiple AF episodes, failed drug therapy. • 82/595 prior failed procedures (8 surgical Maze, 10 multiple RF failures)

  26. Cryoballoon results 2/11 - 12/13 • 124 patients >1 yr f/u 90% NSR, (77% 95/124 NSR off drugs).

  27. Advance Balloon f/u > 12 mo • 50 pts ablated between 6/12 and 11/12 • 47/50 f/u data available • 39/47 cured (no AF no AAD) (83%) • 4/47 brief AF no AAD • 2/47 no AF remain on AAD • 2/47 failures (4%) 96 %

  28. Advance Balloon f/u > 12 mo PAF only • 62 pts f/u between 6/14 and 8/14 • 12 month survey data available on all • 51/62 cured (no AF no AAD) (82%) • 7/62 better (brief symptoms no AAD or no symptoms w/ AAD (11%) • 4/62 failures (7%) 93 %

  29. Immediate Lab Complications (18/595 = 3%) • 7 groin hematoma (1.1%) (no intervention required) • 2 hypotension/acidosis • 1 hyperkalemia • 1 phenylepherine IV extravasation • 2 hematuria from foley placement • 1 ileus • 1 temporary pacing overnight for bradycardia • 1 cath/stent • 2 CHF exacerbation

  30. Phrenic nerve palsy (N=595) • 44 Phrenic nerve palsy (7.4%) • 40 transient with full recovery in lab. • 4 persistent at discharge, 3 with full recovery by 3 months, 1 recovery in 12 months.

  31. Late Complications (N=595) • 0 CVA ,TIA,MI, or embolism • 0 Tamponade • 0 EA fistula • 0 Deaths • 0 persistent phrenic nerve palsy (1 yr)

  32. “… the success of Pulmonary Vein Antral Isolation can exceed 90%, sometimes requiring 2 procedures, and there is an associated risk of stroke <1%, cardiac perforation <1%, pulmonary vein stenosis <1%, vascular injury <1%, and atrioesophageal fistula 1/1000.”

  33. Repeat Procedures • 25 %-33% with RF • 30/595 (5.0%) with Cryo

  34. Goals • Improve efficacy • Decrease complications • Decrease repeat procedures • Minimize iatrogenic arrhythmias ( LA flutter) • Decrease lab time or minimize variability

  35. Total Lab Time

  36. Long-term Outcomes • N= 605 (579 PAF) • 18-48 month f/u ( median 30 month) • 61.6% single procedure • 74.9% multiple procedure • PNP 2% ( last 420 patients 0.7%) Vogt J, et al. JACC 2013;61:1707-12

  37. AF AblationThe “Cure”….where are we ? • The concepts are good • The tools are getting better • Current techniques are becoming more practical for widespread application • Safety remains a concern

  38. AF ablation remains a second line therapy for highly symptomatic patients who fail medical management or cannot /will not take medications (2006) or first line therapy for selected patients (2011)

  39. Things to consider • This is great for symptomaticparoxysmal AF • It is a 2 hour procedure under a general anesthetic • Requires anticoagulation with warfarin • It does not change your CHADS score • It doesn’t work in everybody • There are serious potential complications

More Related